These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3774852)

  • 41. Endotoxin, PAF and arterial thrombosis.
    Bourgain RH; Andries R; Braquet P
    J Lipid Mediat; 1990; 2 Suppl():S187-93. PubMed ID: 2133281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes.
    Sperling RI; Robin JL; Kylander KA; Lee TH; Lewis RA; Austen KF
    J Immunol; 1987 Dec; 139(12):4186-91. PubMed ID: 2826583
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of PAF-acether (platelet-activating factor) biosynthesis in cultured human vascular endothelial cells stimulated with thrombin.
    Hirafuji M; Mencia-Huerta JM; Benveniste J
    Biochim Biophys Acta; 1987 Oct; 930(3):359-69. PubMed ID: 2888488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Failure of PAF-acether to induce in vivo neutrophil migration.
    Cunha FQ; Heluy-Neto NE; Klein A; Souza GE; Ferreira SH
    Agents Actions; 1988 Aug; 25(1-2):191-4. PubMed ID: 3055873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon-gamma enhances PAF-acether production by stimulated human polymorphonuclear leucocytes.
    Geffner JR; Schattner MA; Lazzari MA; Isturiz MA
    Scand J Immunol; 1991 May; 33(5):575-8. PubMed ID: 1903211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ether-phospholipid composition in neutrophils and platelets.
    Tencé M; Jouvin-Marche E; Bessou G; Record M; Benveniste J
    Thromb Res; 1985 May; 38(3):207-14. PubMed ID: 4024039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Unsaturated platelet-activating factor: influence on aggregation, serotonin release and thromboxane synthesis of human thrombocytes.
    Korth R; Riess H; Brehm G; Hiller E
    Thromb Res; 1986 Mar; 41(5):699-706. PubMed ID: 3961742
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Translocation of exogenous platelet-activating factor and its lyso-compound through plasma membranes is a rate-limiting step for their metabolic conversions into alkylacylglycerophosphocholines in rabbit platelets and guinea-pig leukocytes.
    Tokumura A; Tsutsumi T; Yoshida J; Tsukatani H
    Biochim Biophys Acta; 1990 May; 1044(1):91-100. PubMed ID: 2340312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles.
    Tamargo J; Tejerina T; Delgado C; Barrigon S
    Eur J Pharmacol; 1985 Feb; 109(2):219-27. PubMed ID: 3996472
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phospholipase C from Clostridium perfringens stimulates formation and release of platelet-activating factor (PAF-acether) in cultured intestinal epithelial cells (INT 407).
    Gustafson C; Kald B; Sjödahl R; Tagesson C
    Scand J Gastroenterol; 1991 Oct; 26(10):1000-6. PubMed ID: 1947765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
    Simon MF; Chap H; Braquet P; Douste-Blazy L
    Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen-initiated release of platelet-activating factor (PAF-acether) from mouse bone marrow-derived mast cells sensitized with monoclonal IgE.
    Mencia-Huerta JM; Lewis RA; Razin E; Austen KF
    J Immunol; 1983 Dec; 131(6):2958-64. PubMed ID: 6315819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Platelet-activating factor (PAF-acether): present status.
    Benveniste J
    Agents Actions; 1981 Dec; 11(6-7):542-4. PubMed ID: 6176101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
    Touqui L; Jacquemin C; Vargaftig BB
    Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of the binding of platelet-activating factor to platelets of different animal species.
    Iñarrea P; Gomez-Cambronero J; Nieto M; Crespo MS
    Eur J Pharmacol; 1984 Oct; 105(3-4):309-15. PubMed ID: 6510472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
    Chignard M; Wal F; Lefort J; Vargaftig BB
    Eur J Pharmacol; 1982 Feb; 78(1):71-9. PubMed ID: 6804248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.
    Stahl GL; Lefer DJ; Lefer AM
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Oct; 336(4):459-63. PubMed ID: 3431598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.
    Touvay C; Vilain B; Etienne A; Sirois P; Borgeat P; Braquet P
    Immunopharmacology; 1986 Oct; 12(2):97-104. PubMed ID: 3021651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.